AMY WILLINGHAM: Open Payments
NPI 1659649846 · CAPE GIRARDEAU, MO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,563 in 102 payments from 17 companies in 2025. Trend: 2023 $2,721 · 2024 $2,947 · 2025 $2,563
Food & beverage: $2,379Education: $184
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $503 |
| UCB, Inc. | 10 | $292 |
| GENZYME CORPORATION | 8 | $285 |
| Lilly USA, LLC | 8 | $279 |
| LEO Pharma Inc. | 9 | $242 |
| Janssen Biotech, Inc. | 8 | $193 |
| Novartis Pharmaceuticals Corporation | 7 | $131 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $115 |
| Regeneron Healthcare Solutions, Inc. | 3 | $96 |
| Amgen Inc. | 4 | $93 |
Products named: RINVOQ, Bimzelx, DUPIXENT, TREMFYA, SKYRIZI, TALTZ, ADBRY, COSENTYX.
Industry payments across MO — which companies pay providers there.
